Healthpeak Properties (NYSE:DOC) PT Raised to $24.00 at Scotiabank

Healthpeak Properties (NYSE:DOC) had its price target upped by Scotiabank from $23.00 to $24.00 in a report released on Monday morning, Benzinga reports. The brokerage currently has a sector outperform rating on the real estate investment trust’s stock.

Other equities research analysts also recently issued research reports about the stock. JPMorgan Chase & Co. lifted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a neutral rating in a research note on Thursday, May 16th. Evercore ISI boosted their price target on Healthpeak Properties from $24.00 to $25.00 and gave the stock an outperform rating in a research note on Wednesday, August 28th. Citigroup boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a neutral rating in a research note on Thursday, August 22nd. StockNews.com upgraded Healthpeak Properties from a sell rating to a hold rating in a research note on Thursday, August 29th. Finally, Royal Bank of Canada boosted their price target on Healthpeak Properties from $22.00 to $25.00 and gave the stock an outperform rating in a research note on Tuesday, July 30th. Six investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $21.75.

Healthpeak Properties Stock Down 0.4 %

DOC opened at $22.14 on Monday. The firm has a 50 day moving average price of $21.37 and a 200 day moving average price of $19.41. The company has a market cap of $15.58 billion, a PE ratio of 63.24, a price-to-earnings-growth ratio of 2.30 and a beta of 1.14. Healthpeak Properties has a 1 year low of $15.24 and a 1 year high of $22.67. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). The business had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The firm’s revenue for the quarter was up 27.5% compared to the same quarter last year. During the same period last year, the company posted $0.45 EPS. Sell-side analysts expect that Healthpeak Properties will post 1.8 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Investors of record on Monday, August 5th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.42%. The ex-dividend date of this dividend was Monday, August 5th. Healthpeak Properties’s dividend payout ratio (DPR) is 342.86%.

Hedge Funds Weigh In On Healthpeak Properties

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. grew its holdings in Healthpeak Properties by 6.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,943,465 shares of the real estate investment trust’s stock worth $52,488,000 after buying an additional 239,972 shares in the last quarter. Norges Bank bought a new stake in shares of Healthpeak Properties in the 4th quarter worth $34,883,000. Isthmus Partners LLC lifted its holdings in shares of Healthpeak Properties by 11.0% in the fourth quarter. Isthmus Partners LLC now owns 639,633 shares of the real estate investment trust’s stock valued at $8,514,000 after buying an additional 63,493 shares during the period. UBS Group AG boosted its stake in Healthpeak Properties by 56.5% during the fourth quarter. UBS Group AG now owns 526,676 shares of the real estate investment trust’s stock valued at $7,010,000 after buying an additional 190,186 shares in the last quarter. Finally, AGF Management Ltd. grew its holdings in Healthpeak Properties by 28.7% during the fourth quarter. AGF Management Ltd. now owns 286,381 shares of the real estate investment trust’s stock worth $3,812,000 after acquiring an additional 63,896 shares during the period. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.